A. Ruelland

651 total citations
28 papers, 476 citations indexed

About

A. Ruelland is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, A. Ruelland has authored 28 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in A. Ruelland's work include Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). A. Ruelland is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). A. Ruelland collaborates with scholars based in France, Belgium and Canada. A. Ruelland's co-authors include D Maugendre, H Allannic, Isabelle Colombet, François Gueyffier, Marie‐Christine Jaulent, Patrice Degoulet, Gilles Châtellier, François Paillard, B. Grosbois and P. Jégo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinica Chimica Acta.

In The Last Decade

A. Ruelland

27 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ruelland France 12 122 106 92 62 58 28 476
Yong-Wha Lee South Korea 15 134 1.1× 69 0.7× 226 2.5× 91 1.5× 64 1.1× 63 639
Branislav Vohnout Slovakia 9 42 0.3× 104 1.0× 95 1.0× 68 1.1× 94 1.6× 20 460
Aparna R. Bitla India 13 48 0.4× 94 0.9× 129 1.4× 61 1.0× 55 0.9× 51 517
Elena Cercas Spain 14 96 0.8× 91 0.9× 160 1.7× 206 3.3× 60 1.0× 17 646
Maria João Meneses Portugal 10 72 0.6× 135 1.3× 108 1.2× 67 1.1× 69 1.2× 21 498
Naping Tang China 21 56 0.5× 109 1.0× 329 3.6× 103 1.7× 79 1.4× 44 1.2k
J. Oiknine Israel 11 101 0.8× 131 1.2× 179 1.9× 90 1.5× 218 3.8× 12 737
Iqra Hameed India 6 26 0.2× 125 1.2× 142 1.5× 80 1.3× 43 0.7× 15 472
Dongqing Zha China 15 68 0.6× 90 0.8× 361 3.9× 70 1.1× 80 1.4× 25 868
Tetsuya Ito Japan 15 87 0.7× 61 0.6× 206 2.2× 46 0.7× 57 1.0× 59 713

Countries citing papers authored by A. Ruelland

Since Specialization
Citations

This map shows the geographic impact of A. Ruelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ruelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ruelland more than expected).

Fields of papers citing papers by A. Ruelland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ruelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ruelland. The network helps show where A. Ruelland may publish in the future.

Co-authorship network of co-authors of A. Ruelland

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ruelland. A scholar is included among the top collaborators of A. Ruelland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ruelland. A. Ruelland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leroy, Hélène, et al.. (2009). A369 Clinical and Biological Features of Biclonal Gammopathies: A Review of 203 Cases. Clinical Lymphoma & Myeloma. 9. S60–S61. 2 indexed citations
2.
Leroy, Hélène, et al.. (2008). Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases. Blood. 112(11). 5151–5151.
4.
Decaux, O., A. Ruelland, & B. Grosbois. (2007). Effect of treatment on biclonal gammopathy associated with Gaucher disease. Journal of Inherited Metabolic Disease. 30(5). 824–824. 2 indexed citations
5.
Portier, Karine, Brieuc de Moffarts, Nathalie Kirschvink, et al.. (2006). The effects of dietary N‐3 and antioxidant supplementation on erythrocyte membrane fatty acid composition and fluidity in exercising horses. Equine Veterinary Journal. 38(S36). 279–284. 15 indexed citations
6.
Decaux, Olivier, Marc Cuggia, A. Ruelland, et al.. (2006). Suivi évolutif des gammapathies monoclonales de signification indéterminée. La Presse Médicale. 35(7-8). 1143–1150. 5 indexed citations
7.
Faou, Anne-Laurence Le, et al.. (2005). Caractéristiques des fumeurs s’adressant aux consultations de tabacologie. Revue des Maladies Respiratoires. 22(5). 739–750. 16 indexed citations
8.
Syeda, Farisa, Bernadette Delplanque, D. Gripois, et al.. (2003). Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men. Nutrition Metabolism and Cardiovascular Diseases. 13(1). 28–36. 13 indexed citations
9.
Ruelland, A., et al.. (2002). Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.. PubMed. 28(4 Pt 1). 297–304. 46 indexed citations
10.
Colombet, Isabelle, A. Ruelland, Gilles Châtellier, et al.. (2000). Models to predict cardiovascular risk: comparison of CART, multilayer perceptron and logistic regression.. PubMed. 156–60. 68 indexed citations
11.
Ruelland, A., et al.. (2000). Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.. PubMed. 26(2). 107–12. 9 indexed citations
12.
Grosbois, B., et al.. (1997). Gammapathie triclonale et syndrome immunoprolifératif malin. La Revue de Médecine Interne. 18(6). 470–473. 18 indexed citations
13.
Ruelland, A., et al.. (1996). Fortuitous diagnosis of the association of hemoglobin J-Broussais with beta + thalassemia.. PubMed. 54(8-9). 321–3. 1 indexed citations
14.
Ruelland, A., et al.. (1995). Serum lipid, apolipoprotein and lipoparticle levels in the human fetus. Prenatal Diagnosis. 15(3). 225–228. 6 indexed citations
15.
Ruelland, A., et al.. (1993). LDL sialic acid content in patients with coronary artery disease. Clinica Chimica Acta. 221(1-2). 127–133. 38 indexed citations
16.
Ruelland, A., et al.. (1993). Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clinica Chimica Acta. 214(2). 227–234. 141 indexed citations
17.
Ruelland, A., et al.. (1990). Cutaneous interstitial fluid protein concentrations in the inflammatory syndrome: Pharmacological consequences. Clinica Chimica Acta. 189(2). 181–189. 11 indexed citations
18.
Ruelland, A., et al.. (1990). Blood chemistry of human fetuses in the second and third trimesters. Prenatal Diagnosis. 10(12). 801–807. 5 indexed citations
19.
Ruelland, A., et al.. (1990). Transitory deficit in high-density lipoproteins and apolipoprotein A-I.. PubMed. 36(3). 580–1. 4 indexed citations
20.
Baffet, Georges, A. Ruelland, Bruno Clément, Élisabeth Le Rumeur, & Siegmund Fischer. (1985). Synthesis and phosphorylation of cytoskeleton components in foetal, regenerating and adult normal rat hepatocytes during culture. Molecular and Cellular Biochemistry. 68(2). 97–105. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026